Related Experiment Video
Updated: Feb 27, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Synthetic essentiality: Targeting tumor suppressor deficiencies in cancer
1Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Abstract:
In this review, we summarize recent work exploring a novel conceptual approach termed "synthetic essentiality" as a means for targeting specific tumor suppressor gene deficiencies in cancer. With the aid of extensive publically available cancer genome and clinical databases, "synthetic essentiality" could be utilized to identify synthetic essential genes, which might be occasionally deleted in some cancers but almost always retained in the context of a specific tumor suppressor deficiency. Synthetic essentiality expands the existing concepts for therapeutic strategies, including oncogene addiction, tumor maintenance, synthetic, and collateral lethality, to provide a framework for the discovery of cancer-specific vulnerabilities. Enabled by ever-expanding large-scale genome datasets and genome-scale functional screens, the "synthetic essentiality" framework provides an avenue for the identification of context-specific therapeutic targets and development of patient responder hypotheses for novel and existing therapies.
Insights
Synthetic essentiality offers a new strategy for cancer therapy by identifying genes crucial for tumors with specific tumor suppressor deficiencies. This approach leverages large cancer genome datasets to find new therapeutic targets.
Area of Science:
- Oncology
- Genomics
- Computational Biology
Background:
- Targeting specific tumor suppressor gene deficiencies in cancer is a key challenge.
- Existing therapeutic strategies like oncogene addiction and synthetic lethality have limitations.
Purpose of the Study:
- To review the novel concept of "synthetic essentiality" for targeting cancer vulnerabilities.
- To explore how synthetic essentiality can be used to identify context-specific therapeutic targets.
Main Methods:
- Utilizing extensive public cancer genome and clinical databases.
- Analyzing large-scale genome datasets and genome-scale functional screens.
- Identifying genes essential in the context of specific tumor suppressor deficiencies.
Main Results:
- Synthetic essentiality can identify genes occasionally deleted in some cancers but retained when tumor suppressor genes are deficient.
- This framework expands upon existing therapeutic concepts.
- It provides a method for discovering cancer-specific vulnerabilities.
Conclusions:
- Synthetic essentiality offers a promising framework for identifying novel cancer-specific therapeutic targets.
- It facilitates the development of patient responder hypotheses for existing and new therapies.
- This approach is enabled by advancements in large-scale genomic data and functional screening.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Replicative Cell Senescence
Abnormal Proliferation

